Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes

Residual risk, the ongoing appreciable risk of major cardiovascular events (MCVE) in statin-treated patients who have achieved evidence-based lipid goals, remains a concern among cardiologists. Factors that contribute to this continuing risk are atherogenic non-low-density lipoprotein (LDL) particle...

Descripción completa

Detalles Bibliográficos
Autor principal: Kones, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808150/
https://www.ncbi.nlm.nih.gov/pubmed/24174878
http://dx.doi.org/10.2147/VHRM.S37119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808150/
https://www.ncbi.nlm.nih.gov/pubmed/24174878
http://dx.doi.org/10.2147/VHRM.S37119

Ejemplares similares